Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Reply.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Antonia, SJ

Published Date

  • March 7, 2019

Published In

Volume / Issue

  • 380 / 10

Start / End Page

  • 990 -

PubMed ID

  • 30855761

Pubmed Central ID

  • 30855761

Electronic International Standard Serial Number (EISSN)

  • 1533-4406

Digital Object Identifier (DOI)

  • 10.1056/NEJMc1900407

Language

  • eng

Conference Location

  • United States